We are live on
!
Find out more
GJIC
Gamble Jones Investment Counsel Portfolio holdings
AUM
$1.33B
1-Year Est. Return
11.55%
This Fund
S&P 500
This Quarter
Est. Return
+2.66%
1 Year Est. Return
-11.55%
3 Year Est. Return
+32.88%
5 Year Est. Return
+72.75%
10 Year Est. Return
–
AUM
$900M
AUM Growth
-$5.99M
(-0.66%)
Cap. Flow
-$24M
Cap. Flow
% of AUM
-2.67%
Top 10 Holdings %
Top 10 Hldgs %
49.21%
Holding
216
New
10
Increased
70
Reduced
98
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Autodesk
ADSK
|
+$2.44M |
| 2 |
Interactive Brokers
IBKR
|
+$1.9M |
| 3 |
American Tower
AMT
|
+$1.47M |
| 4 |
CDK
CDK Global, Inc.
CDK
|
+$1.31M |
| 5 |
Wells Fargo
WFC
|
+$1.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$9.38M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$5.82M |
| 3 |
Microsoft
MSFT
|
+$2.4M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$2.36M |
| 5 |
Motorola Solutions
MSI
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 37.38% |
| 2 | Healthcare | 12.47% |
| 3 | Technology | 10.54% |
| 4 | Industrials | 8.61% |
| 5 | Financials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Labcorp
LH
$26.2B
| $204K | 0.02% |
2,031
| – | – |
|
|
202
Bausch Health
BHC
$2.32B
| – | – |
-92,319
| Closed | -$9.38M |
|
203
CSX Corp
CSX
$92.8B
| – | – |
-23,589
| Closed | -$204K |
|
204
Consolidated Edison
ED
$39.9B
| – | – |
-3,212
| Closed | -$206K |
|
205
Enterprise Products Partners
EPD
$81.9B
| – | – |
-8,185
| Closed | -$209K |
|
206
Freeport-McMoran
FCX
$96.9B
| – | – |
-11,220
| Closed | -$76K |
|
207
McKesson
MCK
$102B
| – | – |
-1,099
| Closed | -$217K |
|
|
208
Motorola Solutions
MSI
$77.7B
| – | – |
-32,381
| Closed | -$2.22M |
|
|
NVO
209
Novo Nordisk
NVO
$203B
| – | – |
-7,060
| Closed | -$205K |
|
210
Welltower
WELL
$166B
| – | – |
-2,954
| Closed | -$201K |
|
|
ESL
211
DELISTED
Esterline Technologies
ESL
| – | – |
-20,736
| Closed | -$1.68M |
|
|
ESRX
212
DELISTED
Express Scripts Holding Company
ESRX
| – | – |
-2,543
| Closed | -$222K |
|
|
CB
213
DELISTED
CHUBB CORPORATION
CB
| – | – |
-5,215
| Closed | -$692K |
|
Similar funds
SBL
TFS
ZCA
S
LWAC
SGA
BOTW
PIM
Gamble Jones Investment Counsel's Q1 2016 Portfolio in Review
As of Q1 2016, Gamble Jones Investment Counsel held 216 positions worth $900M, down 0.66% from $906M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Gamble Jones Investment Counsel's Q1 2016 filing shows 10 new, 70 increased, 98 reduced and 13 closed positions. Its largest new stake was CDK Global, Inc.: 29,407 shares worth $1.37M. The largest sale was Bausch Health, an estimated $9.38M.
By sector, the portfolio is most concentrated in Consumer Staples at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Technology.
- Gamble Jones Investment Counsel's largest Q1 2016 buy was CDK Global, Inc.: 29,407 shares worth $1.37M.
- Gamble Jones Investment Counsel added most to Autodesk in Q1 2016, an estimated $2.44M increase.
- Gamble Jones Investment Counsel's biggest Q1 2016 reduction was Endo International plc, cutting an estimated $5.82M.
- Gamble Jones Investment Counsel fully exited Bausch Health in Q1 2016, selling an estimated $9.38M.
- Gamble Jones Investment Counsel's ten largest holdings make up 49% of its $900M portfolio in Q1 2016.
- Gamble Jones Investment Counsel opened 10 new positions and closed 13 in Q1 2016.
- Gamble Jones Investment Counsel's portfolio value fell 0.66% quarter-over-quarter to $900M.
Based on Gamble Jones Investment Counsel's 13F filing for Q1 2016, filed 2 May 2016.